Search results
Results From The WOW.Com Content Network
In April 2014, The New York Times reported that sluggish cognitive tempo is the subject of pharmaceutical company clinical drug trials, including ones by Eli Lilly that proposed that one of its biggest-selling drugs, Strattera, could be prescribed to treat proposed symptoms of sluggish cognitive tempo. [57]
The emerging concept of sluggish cognitive tempo has also been implicated in the expression of brain fog symptoms. [42] Patients recovering from COVID-19 report experiencing brain fog, which can reflect a wide variety of neurological and psychological symptoms linked to COVID-19. [43]
Cognitive Tempo (a term of cognitive psychology, ... Sluggish cognitive tempo (SCT) References. Works. Development of Cognitive Tempo; Galotti, K. (2008). "Cognitive ...
"One fairly common feature of cognitive impairments in children with specific learning disorders is a significant and long-lasting tendency to struggle with temporal notions and representations, such as situating themselves in time, in all its dimensions (hours, days, weeks, etc….)."
The study found that 15.3% of participants had mild cognitive impairment, and that women with mild cognitive impairment were more likely to report more severe menopause symptoms.
The person may have slow thinking and possible memory time loss. This could be caused by sleep deprivation, malnutrition, allergies, environmental pollution, drugs (prescription and nonprescription), and infection. Delirious: Disoriented; restlessness, hallucinations, sometimes delusions
Cognitive impairment is an inclusive term to describe any characteristic that acts as a barrier to the cognition process or different areas of cognition. [1] Cognition, also known as cognitive function, refers to the mental processes of how a person gains knowledge, uses existing knowledge, and understands things that are happening around them using their thoughts and senses. [2]
When the two groups were compared using standard cognitive tests, the researchers found the patients receiving TMS therapy had a 44% slower rate of symptoms worsening.